Amgen Up Over 12%, On Track for Largest Percent Increase Since July 2009 — Data Talk
Amgen Inc. (AMGN) is currently at $313.67, up $35.28 or 12.67%
--Would be highest close since Feb. 6, 2024, when it closed at $316.07
--On pace for largest percent increase since July 8, 2009, when it rose 13.92%
--Currently up five of the past six days
--Currently up three consecutive days; up 14.5% over this period
--Best three day stretch since the three days ending July 8, 2009, when it rose 15.6%
--Up 8.91% year-to-date
--Down 3.35% from its all-time closing high of $324.56 on Feb. 1, 2024
--Up 32.61% from 52 weeks ago (May 5, 2023), when it closed at $236.53
--Down 3.35% from its 52-week closing high of $324.56 on Feb. 1, 2024
--Up 46.39% from its 52-week closing low of $214.27 on June 1, 2023
--Traded as high as $322.60; highest intraday level since Feb. 6, 2024, when it hit $326.96
--Up 15.88% at today's intraday high; largest intraday percent increase since July 8, 2009, when it rose as much as 16.7%
--Best performer in the DJIA today
--Best performer in the S&P 500 today
--Best performer in the Nasdaq 100 today
--Contributed 231.78 points to the DJIA so far today
All data as of 9:47:11 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 03, 2024 10:05 ET (14:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
What Does Nvidia’s Stock Split Mean for Investors?
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy
-
Nio Earnings: Revenue and Loss Largely In Line, but Vehicle Margin Missed Amid Price Competition
-
The Best Biotech Stocks to Buy
-
After Earnings, Is Marvell Stock a Buy, a Sell, or Fairly Valued?
-
Nvidia Raised Its Dividend — but There’s a Catch